Outlook Pharmaceuticals Report issue

For profit Phase 3
Founded: Cincinnati OH United States (2004)

Organization Overview

First Clinical Trial
2018
NCT03844074
First Marketed Drug
2008
amphetamine (Adderall)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

OUTLOOK PHARMS | Outlook Therapeutics, Inc.